JPM fund nets $328m from Celltrion Healthcare block

By Jonathan Breen
21 May 2019

JP Morgan’s private equity arm has bagged W390.7bn ($327.5m) after selling a chunk of shares in South Korean firm Celltrion Healthcare, according to a source close to the deal.

The vendor, One Equity Partners, launched the trade at around 3pm Hong Kong time, after local markets had closed. It came out looking to offload 6.5m shares.

Sole bookrunner UBS marketed the stock at a range of W60,100 to W62,000, treating investors to a potential discount of 5.1% ...

Please take a trial or subscribe to access this content.

Contact our subscriptions team to discuss your access:

Or sign up for a trial to gain full access to the entire site for a limited period.

Free Trial

Corporate access

To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: or find out more online here.